When to start antiretroviral therapy in HIV-associated tuberculosis
- PMID: 22010921
- DOI: 10.1056/NEJMe1109546
When to start antiretroviral therapy in HIV-associated tuberculosis
Comment in
-
Timing of antiretroviral therapy for HIV-1-associated tuberculosis.N Engl J Med. 2012 Feb 2;366(5):474-5; author reply 476. doi: 10.1056/NEJMc1113986. N Engl J Med. 2012. PMID: 22296085 No abstract available.
Comment on
-
Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.N Engl J Med. 2011 Oct 20;365(16):1471-81. doi: 10.1056/NEJMoa1013911. N Engl J Med. 2011. PMID: 22010913 Free PMC article. Clinical Trial.
-
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.N Engl J Med. 2011 Oct 20;365(16):1482-91. doi: 10.1056/NEJMoa1013607. N Engl J Med. 2011. PMID: 22010914 Free PMC article. Clinical Trial.
-
Integration of antiretroviral therapy with tuberculosis treatment.N Engl J Med. 2011 Oct 20;365(16):1492-501. doi: 10.1056/NEJMoa1014181. N Engl J Med. 2011. PMID: 22010915 Free PMC article. Clinical Trial.
Similar articles
-
Timing of antiretroviral therapy for HIV-1-associated tuberculosis.N Engl J Med. 2012 Feb 2;366(5):474-5; author reply 476. doi: 10.1056/NEJMc1113986. N Engl J Med. 2012. PMID: 22296085 No abstract available.
-
Timing of antiretroviral therapy for HIV-1-associated tuberculosis.N Engl J Med. 2012 Feb 2;366(5):474; author reply 475-6. doi: 10.1056/NEJMc1113986. N Engl J Med. 2012. PMID: 22296084 No abstract available.
-
Timing of antiretroviral drugs during tuberculosis therapy.N Engl J Med. 2010 Jun 3;362(22):2137; author reply 2138-9. doi: 10.1056/NEJMc1003767. N Engl J Med. 2010. PMID: 20519688 No abstract available.
-
When should antiretroviral treatment be started in patients with HIV-associated tuberculosis in South Africa?S Afr Med J. 2007 Jun;97(6):412, 414-5. S Afr Med J. 2007. PMID: 17691468 Review. No abstract available.
-
[Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].Kekkaku. 2007 Nov;82(11):845-8. Kekkaku. 2007. PMID: 18078110 Review. Japanese.
Cited by
-
Prediction of pulmonary tuberculosis treatment outcome in a sub-Saharan African context.J Public Health Afr. 2023 Oct 1;14(10):2694. doi: 10.4081/jphia.2023.2694. eCollection 2023 Oct 31. J Public Health Afr. 2023. PMID: 38020279 Free PMC article.
-
Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study).AIDS Res Ther. 2019 Nov 15;16(1):34. doi: 10.1186/s12981-019-0250-2. AIDS Res Ther. 2019. PMID: 31729999 Free PMC article. Clinical Trial.
-
Impact of combination antiretroviral therapy initiation on adherence to antituberculosis treatment.South Afr J HIV Med. 2015 Oct 8;16(1):346. doi: 10.4102/sajhivmed.v16i1.346. eCollection 2015. South Afr J HIV Med. 2015. PMID: 29568579 Free PMC article.
-
Global HIV neurology: a comprehensive review.AIDS. 2019 Feb 1;33(2):163-184. doi: 10.1097/QAD.0000000000001796. AIDS. 2019. PMID: 29547440 Free PMC article.
-
Human Immunodeficiency Virus in the Brain-Culprit or Facilitator?Infect Dis (Auckl). 2018 Feb 14;11:1178633717752687. doi: 10.1177/1178633717752687. eCollection 2018. Infect Dis (Auckl). 2018. PMID: 29467577 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical